Recently Diagnosed or Relapsed? Stopping Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Multiple Myeloma, Pharmacologically-dosed ascorbic acid (PAA)

Share Button

Pharmacologically-dosed ascorbic acid (PAA) selectively kills CD138+MM tumor cells derived from MM and smoldering MM (SMM)

Leukemia, lymphoma and multiple myeloma all have a robust collection of FDA approved,  standard-of-care conventional therapies that your oncologist can provide. Unfortunately, these blood cancers often relapse once your blood cancer becomes resistant to conventional therapies. Further, all toxic conventional therapies cause short, long-term and late-stage collateral damage that may limit their use. Whether you are looking for a first-line therapy, integrative therapy or refractory therapy, there may come a time when you want to learn about non-conventional therapies for your blood cancer.

Intravenous vitamin C may be an evidence-based non-conventional therapy that can treat your blood cancer.

I was diagnosed with multiple myeloma in early 1994. I underwent several years of aggressive conventional therapies such as an autologous stem cell transplant. My oncologist told me that there was nothing more that she could do for me in September of 1997.

I have remained in complete remission from my “incurable cancer” since 1999 by living an evidence-based, non-toxic, anti-MM lifestyle through nutrition, supplementation, bone health, etc.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Click here to follow along with the Introduction Guide

Click here to get your FREE First Questions Guide

MM patients and survivors must look beyond convention myeloma therapies if they want to manage their myeloma for the long-term.

For more information about evidence-based, non-conventional therapies for your multiple myeloma, scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • MM survivor
  • MM Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:

Our Next Show: The Myeloma-Killing Effects of Intravenous Vitamin C

“Today’s myeloma therapy can help patients gain remission, but the combinations can cause their own side effects because they target normal cells as well as cancer cells. Investigators at the University of Iowa including Dr. Guido Tricot and Dr. Frank Zhan have tested mega-doses of Vitamin C in combination with the standard chemo melphalan and found that the Vitamin C can kill myeloma cells while not affecting normal cells…”

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid

High-dose chemotherapies to treat multiple myeloma (MM) can be life-threatening due to toxicities to normal cells and there is a need to target only tumor cells and/or lower standard drug dosage without losing efficacy.

We show that pharmacologically-dosed ascorbic acid (PAA), in the presence of iron, leads to the formation of highly reactive oxygen species (ROS) resulting in cell death. PAA selectively kills CD138+MM tumor cells derived from MM and smoldering MM (SMM) but not from monoclonal gammopathy undetermined significance (MGUS) patients. PAA alone or in combination with melphalan inhibits tumor formation in MM xenograft mice. This study shows PAA efficacy on primary cancer cells and cell lines in vitro and in vivo

UI researchers discover vitamin C may offer new treatment option for multiple myeloma

“University of Iowa researchers in the Holden Comprehensive Cancer Center Multiple Myeloma Program recently found evidence that mega doses of vitamin C delivered intravenously may offer new hope to people diagnosed with multiple myeloma. The results of their study were recently published in the international journal EBioMedicine…”




Leave a Comment:

Add Your Reply